Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (4782)	7/7/1998 9:38:00 AM
From: Peter Singleton	of 6136

Henry, do you have any thoughts on Remune or IMNR? Peter btw, in the interests of full disclosure, I took a trading position in IMNR after the AGPH deal ... but don't consider myself fundamentally long or short on the company, since I don't know enough. I think the data on Remune are very interesting and very promising, though we need to see how changes in immune system markers translate into clinical benefit. In some ways, IMNR's development efforts appear to have suffered from the lack of understanding in the past of the importance of the immune system in a patient's success or lack of in fighting HIV. And it's still not clear what the appropriate markers are ... why Remune trials have to pave new ground. But interested in hearing your take. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next